Tumefactive demyelinating lesions: nine cases and a review of the literature
- PMID: 19172322
- DOI: 10.1007/s10143-009-0185-5
Tumefactive demyelinating lesions: nine cases and a review of the literature
Abstract
Tumefactive demyelinating lesions (TDLs) are misdiagnosed frequently. To investigate the characteristics of TDLs, clinical and radiological data from nine cases with TDLs were analyzed after admission. All cases underwent surgery and pathological examination; some received postoperative steroid therapy. Onsets were mostly within 3 weeks and main presentation included intracranial hypertension, extremity weakness, epilepsy, and visual disturbance. Symptoms in children were acute and severe, frequently including headache, vomiting, and visual disturbance. Most intracephalic lesions were in cerebral hemispheres. All intraspinal lesions were in cervical segments. Radiological features included mass effect, perifocal edema and enhancement (of which open-ring enhancement was diagnostic), and decreased relative cerebral blood volume. Intraoperative frozen section did not confirm the diagnosis, while postoperative paraffin section did confirm it (by evidence of macrophage infiltration). The patients responded well to steroid therapy and no relapse was found during following up. Thus, intensive analysis of both clinical and radiological data may provide some clues for diagnosis. For suspected cases, it is advisable to take steroid therapy or undergo advanced radiological examinations, such as serial magnetic resonance spectroscopy. However, in difficult cases, pathological evidence is beneficial to a final diagnosis.
Similar articles
-
Dynamic contrast-enhanced T2*-weighted MR imaging of tumefactive demyelinating lesions.AJNR Am J Neuroradiol. 2001 Jun-Jul;22(6):1109-16. AJNR Am J Neuroradiol. 2001. PMID: 11415906 Free PMC article.
-
Kidney Transplant Recipient With Tumefactive Demyelinating Lesions: A Case Report and Literature Review.Transplant Proc. 2023 Oct;55(8):1906-1909. doi: 10.1016/j.transproceed.2023.07.006. Epub 2023 Aug 3. Transplant Proc. 2023. PMID: 37541863 Review.
-
Clinical and radiological characteristics of tumefactive demyelinating lesions: follow-up study.Mult Scler. 2012 Oct;18(10):1448-53. doi: 10.1177/1352458512438237. Epub 2012 Mar 14. Mult Scler. 2012. PMID: 22419670
-
Pediatric tumefactive demyelination: case series and review of the literature.Pediatr Neurol. 2002 Jan;26(1):18-25. doi: 10.1016/s0887-8994(01)00322-8. Pediatr Neurol. 2002. PMID: 11814730 Review.
-
Performance of Apparent Diffusion Coefficient Values and Conventional MRI Features in Differentiating Tumefactive Demyelinating Lesions From Primary Brain Neoplasms.AJR Am J Roentgenol. 2015 Nov;205(5):1075-85. doi: 10.2214/AJR.14.13970. AJR Am J Roentgenol. 2015. PMID: 26496556 Free PMC article.
Cited by
-
Gadolinium enhancement patterns of tumefactive demyelinating lesions: correlations with brain biopsy findings and pathophysiology.J Neurol. 2014 Oct;261(10):1902-10. doi: 10.1007/s00415-014-7437-1. Epub 2014 Jul 18. J Neurol. 2014. PMID: 25034274
-
Differential Diagnosis of Tumor-like Brain Lesions.Neurol Clin Pract. 2023 Oct;13(5):e200182. doi: 10.1212/CPJ.0000000000200182. Epub 2023 Aug 30. Neurol Clin Pract. 2023. PMID: 37664132 Free PMC article. Review.
-
Clinical spectrum and prognosis of pathologically confirmed atypical tumefactive demyelinating lesions.Sci Rep. 2023 May 13;13(1):7773. doi: 10.1038/s41598-023-34420-4. Sci Rep. 2023. PMID: 37179394 Free PMC article.
-
Tumefactive multiple sclerosis versus high grade glioma: A diagnostic dilemma.Surg Neurol Int. 2022 Apr 15;13:146. doi: 10.25259/SNI_239_2022. eCollection 2022. Surg Neurol Int. 2022. PMID: 35509579 Free PMC article.
-
Solitary tumefactive demyelinating pseudotumor masquerading as a low-grade glioma in a child.Childs Nerv Syst. 2019 Dec;35(12):2255-2257. doi: 10.1007/s00381-019-04409-4. Epub 2019 Oct 29. Childs Nerv Syst. 2019. PMID: 31664559 No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical